SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1386)6/19/1998 10:59:00 AM
From: macker  Read Replies (1) | Respond to of 5402
 
thats my point exactly, we wont be sgnc by the time the product ever came to market, we will be long gone before then.

macker



To: Andrew H who wrote (1386)6/19/1998 11:21:00 AM
From: drdan  Read Replies (1) | Respond to of 5402
 
Andrew, until the drug gets to phase two trials , when therapeutc doses are tested for safety and efficacy, or until the drug falls on its face during phase 1 trials(which is highly unlikely, IMO), the issue of drug approval isn't important. all that people need to see now is that a big pharma player has the confidence in this product ,and whatever is known about it NOW, to sink the needed money into it for research.

have a good day...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News